Medicamen Organics Ltd

Medicamen Organ. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Medicamen Organics Ltd

₹ 26.0 3.17%
12 Dec - close price
medicamenorganics.com NSE - SME: MEDIORG
About

Incorporated in 1995, Medicamen Organics Ltd develops, manufactures, and distributes a broad range of pharmaceutical dosages including generic dosage[1]

Key Points

Business Overview:[1][2]
MOL specializes in manufacturing and distributing tablets, capsules, syrups, and ointments. It offers B2B contract and third-party manufacturing services for pharma companies in India and globally. Its portfolio includes generic and branded formulations, catering to government sectors, private institutions, and prominent pharma firms. Products are marketed via third-party distributors and loan licensing agreements.

Website NSE - SM
  • Market Cap ₹ 30.4 Cr.
  • Current Price ₹ 26.0
  • High / Low ₹ 58.6 / 19.6
  • Stock P/E 6.64
  • Book Value ₹ 27.9
  • Dividend Yield 0.00 %
  • ROCE 16.9 %
  • ROE 17.8 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Stock is trading at 0.93 times its book value

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company might be capitalizing the interest cost
  • Company has high debtors of 247 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Half Yearly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2024 Sep 2024 Mar 2025 Sep 2025
13.95 16.61 21.58 17.85
11.62 13.88 17.73 14.43
Operating Profit 2.33 2.73 3.85 3.42
OPM % 16.70% 16.44% 17.84% 19.16%
0.01 0.04 0.05 0.06
Interest 0.36 0.22 0.29 0.33
Depreciation 0.36 0.36 0.37 0.41
Profit before tax 1.62 2.19 3.24 2.74
Tax % 22.84% 30.59% 21.60% 25.55%
1.26 1.51 2.54 2.04
EPS in Rs 1.47 1.29 2.17 1.74
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2024 Mar 2025 TTM
25.27 38.19 39.43
20.53 31.58 32.16
Operating Profit 4.74 6.61 7.27
OPM % 18.76% 17.31% 18.44%
1.07 0.10 0.11
Interest 0.65 0.54 0.62
Depreciation 0.72 0.74 0.78
Profit before tax 4.44 5.43 5.98
Tax % 40.77% 25.41%
2.62 4.05 4.58
EPS in Rs 3.05 3.46 3.91
Dividend Payout % 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 29%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 65%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -57%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 18%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2024 Mar 2025 Sep 2025
Equity Capital 8.60 11.70 11.70
Reserves 6.66 18.43 20.92
12.66 12.35 15.67
10.52 16.73 12.86
Total Liabilities 38.44 59.21 61.15
10.35 10.13 12.79
CWIP 0.15 2.22 0.36
Investments 0.00 0.00 0.00
27.94 46.86 48.00
Total Assets 38.44 59.21 61.15

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2024 Mar 2025
-3.66 -4.54
-0.34 -2.35
4.01 10.47
Net Cash Flow 0.01 3.58

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2024 Mar 2025
Debtor Days 241.21 247.06
Inventory Days 244.39 228.39
Days Payable 281.81 356.77
Cash Conversion Cycle 203.80 118.69
Working Capital Days 74.24 135.14
ROCE % 16.88%

Shareholding Pattern

Numbers in percentages

Sep 2024Mar 2025Sep 2025
59.69% 59.73% 59.73%
0.14% 0.07% 0.07%
3.76% 3.79% 3.69%
36.41% 36.41% 36.51%
No. of Shareholders 379460507

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Concalls